Pharma Stock Finds Grounding Despite Pulled Application

NVS is seeing attractively priced premiums at the moment

Deputy Editor
Jun 29, 2020 at 10:49 AM
facebook X logo linkedin


The shares of Novartis AG (NYSE:NVS) are up 0.8% at last check, after receiving approval for five new products from the Japanese Ministry of Health, Labour and Welfare. Over the weekend, however, Novartis pulled its application for European approval of its dry-eye drug Xiidra, after regulators said its effectiveness had not been demonstrated. Japan's Takeda, which sold Xiidra to Novartis for $3.4 billion upfront with an additional $1.9 billion in potential milestone receipts in July of 2019, also stands to lose around $200 million from this withdrawal. Meanwhile, the drug is already approved in the U.S.

Consistently tapering off after reaching the $91 region for the past two months, NVS is still up 7% in the last three. More recently, the stock has found support at the 30-day moving average, where a pullback was caught at $87.

Analysts are, for the most part, bullish on Novartis stock, with five out of seven sporting a "strong buy" rating. Meanwhile, the 12-month consensus price target of $104 is an 18.8% premium to current levels. 

That said, speculating on NVS' next move with options could be a prudent play.The stock's Schaeffer's Volatility Index (SVI) of 24% stands higher than just 18% of all other readings in its annual range, implying that options players are pricing in relatively low volatility expectations at the moment. 

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI